Company Overview of G2B Pharma, Inc.
Key Executives for G2B Pharma, Inc.
|Nigel Ten Fleming Ph.D.||34 Relationships||Co-Founder, Chairman and Chief Executive Officer||64|
|Michael Doodson FCMA, BA||9 Relationships||Co-Founder and Executive Chairman||--|
|Douglas B. Evans||No Relationships||Corporate Counsel||--|
|Ted Lanpher||2 Relationships||Vice President of Business Development||--|
|Robert P. Cook||5 Relationships||Senior Vice President of Sales and Marketing||85|
G2B Pharma, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Nigel Ten Fleming Ph.D.||34 Relationships||A-CUBE, Inc.||64|
|Michael Doodson FCMA, BA||9 Relationships||G2B Pharma, Inc.||--|
|Joaquim Trias Ph.D.||29 Relationships||Tetraphase Pharmaceuticals, Inc.||--|
|Richard Chin M.D.||98 Relationships||Kindred Biosciences, Inc.||50|
|Michael Kaliner M.D.||9 Relationships||G2B Pharma, Inc.||--|
G2B Pharma, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board Ph.D.||Joaquim Trias||29 Relationships||6 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.